The CBFβ-MYH11 fusion arising from inv(16) rearrangement was reported to lead to differentiation blockage of normal myeloid cells and result in AML, but whether this fusion blocks specific cell commitment has not been discerned. This evidence concerns the gene CBFB and acute myeloid leukemia.